Emmessar Biotech & Nutrition submits copy of revised financial results
26 Dec 2015
Emmessar Biotech & Nutrition has submitted a copy of the Revised Financial Results for the period ended September 30, 2015 with the necessary corrections duly done in Profit Before Tax in the Segment wise section.
The above information is a part of company’s filings submitted to BSE.
Related Emmessar Biotech & Nutrition Ltd. Links:
11.00
0.00 (0.00%)
Nov 15, 18:01
1 Year Price Chart
Peers
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 424.35 |
| Lupin | 746.30 |
| Dr. Reddys Lab | 2736.10 |
| Piramal Enterprises | 1746.75 |
| Cadila Healthcare | 241.35 |
| View more.. | |
Sensex vs Emmessar Biotech&Nut
